Ausdal Financial Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.57M | Buy |
21,392
+4,639
| +28% | +$536K | 0.11% | 189 |
|
|
2025
Q4 | $1.76M | Sell |
16,753
-2,075
| -11% | -$195K | 0.08% | 244 |
|
|
2025
Q3 | $1.58M | Buy |
18,828
+9,731
| +107% | +$801K | 0.08% | 259 |
|
|
2025
Q2 | $720K | Buy |
9,097
+2,439
| +37% | +$194K | 0.05% | 329 |
|
|
2025
Q1 | $598K | Sell |
6,658
-640
| -9% | -$59.8K | 0.05% | 350 |
|
|
2024
Q4 | $726K | Sell |
7,298
-1,440
| -16% | -$148K | 0.06% | 261 |
|
|
2024
Q3 | $992K | Sell |
8,738
-249
| -3% | -$29.6K | 0.1% | 195 |
|
|
2024
Q2 | $1.11M | Buy |
8,987
+526
| +6% | +$67.8K | 0.12% | 174 |
|
|
2024
Q1 | $1.12M | Sell |
8,461
-485
| -5% | -$59.8K | 0.13% | 162 |
|
|
2023
Q4 | $975K | Sell |
8,946
-25
| -0.3% | -$2.6K | 0.12% | 164 |
|
|
2023
Q3 | $924K | Sell |
8,971
-533
| -6% | -$57.4K | 0.13% | 161 |
|
|
2023
Q2 | $1.1M | Buy |
9,504
+1,055
| +12% | +$120K | 0.15% | 154 |
|
|
2023
Q1 | $899K | Buy |
8,449
+668
| +9% | +$72.1K | 0.12% | 173 |
|
|
2022
Q4 | $863K | Buy |
7,781
+2,214
| +40% | +$226K | 0.13% | 174 |
|
|
2022
Q3 | $479K | Buy |
5,567
+353
| +7% | +$31.5K | 0.08% | 249 |
|
|
2022
Q2 | $475K | Buy |
5,214
+420
| +9% | +$37.2K | 0.07% | 270 |
|
|
2022
Q1 | $393K | Sell |
4,794
-3,222
| -40% | -$254K | 0.05% | 325 |
|
|
2021
Q4 | $614K | Buy |
8,016
+786
| +11% | +$62.6K | 0.08% | 251 |
|
|
2021
Q3 | $543K | Sell |
7,230
-43
| -0.6% | -$3.27K | 0.08% | 260 |
|
|
2021
Q2 | $566K | Sell |
7,273
-742
| -9% | -$55.2K | 0.09% | 241 |
|
|
2021
Q1 | $590K | Sell |
8,015
-200
| -2% | -$14.8K | 0.1% | 223 |
|
|
2020
Q4 | $641K | Buy |
8,215
+1,837
| +29% | +$140K | 0.12% | 188 |
|
|
2020
Q3 | $505K | Buy |
6,378
+271
| +4% | +$21.2K | 0.12% | 184 |
|
|
2020
Q2 | $451K | Sell |
6,107
-35
| -0.6% | -$2.63K | 0.15% | 155 |
|
|
2020
Q1 | $487K | Sell |
6,142
-328
| -5% | -$25.8K | 0.17% | 139 |
|
|
2019
Q4 | $539K | Sell |
6,470
-1,300
| -17% | -$107K | 0.16% | 160 |
|
|
2019
Q3 | $624K | Buy |
7,770
+114
| +1% | +$9.14K | 0.22% | 119 |
|
|
2019
Q2 | $608K | Buy |
7,656
+4
| +0.1% | +$306 | 0.23% | 115 |
|
|
2019
Q1 | $607K | Buy |
7,652
+668
| +10% | +$50K | 0.25% | 103 |
|
|
2018
Q4 | $509K | Sell |
6,984
-3,263
| -32% | -$230K | 0.25% | 101 |
|
|
2018
Q3 | $694K | Sell |
10,247
-5
| -0% | -$319 | 0.2% | 146 |
|
|
2018
Q2 | $594K | Buy |
10,252
+2,004
| +24% | +$113K | 0.18% | 166 |
|
|
2018
Q1 | $429K | Buy |
8,248
+948
| +13% | +$51.2K | 0.15% | 195 |
|
|
2017
Q4 | $392K | Buy |
7,300
+1,963
| +37% | +$109K | 0.14% | 206 |
|
|
2017
Q3 | $326K | Sell |
5,337
-14
| -0.3% | -$849 | 0.13% | 209 |
|
|
2017
Q2 | $327K | Sell |
5,351
-356
| -6% | -$21.7K | 0.14% | 201 |
|
|
2017
Q1 | $346K | Sell |
5,707
-1,019
| -15% | -$61.8K | 0.16% | 174 |
|
|
2016
Q4 | $378K | Buy |
6,726
+388
| +6% | +$22.7K | 0.18% | 151 |
|
|
2016
Q3 | $377K | Buy |
6,338
+922
| +17% | +$53.9K | 0.19% | 143 |
|
|
2016
Q2 | $298K | Sell |
5,416
-61
| -1% | -$3.25K | 0.15% | 163 |
|
|
2016
Q1 | $276K | Buy |
5,477
+200
| +4% | +$9.79K | 0.16% | 162 |
|
|
2015
Q4 | $266K | Buy |
+5,277
| New | +$266K | 0.13% | 170 |
|
Other funds holding MRK
VCM
VPM
Ausdal Financial Partners's MRK Position: Q1 2026 in Review
Ausdal Financial Partners increased its Merck (MRK) stake by 28% in Q1 2026, buying an estimated $536K and bringing the position to 21,392 shares worth $2.57M. The position accounts for 0.11% of the portfolio, ranked #189.
Ausdal Financial Partners first reported a position in MRK in Q4 2015 and has held it in 42 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Ausdal Financial Partners held 21,392 shares of Merck worth $2.57M as of Q1 2026.
- Ausdal Financial Partners bought 4,639 Merck shares in Q1 2026, an estimated $536K.
- Merck made up 0.11% of Ausdal Financial Partners's portfolio in Q1 2026, its #189 holding.
- Ausdal Financial Partners first reported a position in Merck in Q4 2015 and has held it in 42 quarters since.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Ausdal Financial Partners's 13F filing for Q1 2026, filed 12 May 2026.